Detecting Recurrent Prostate Cancer With 11C-choline Positron Emission Tomography
Status:
No longer available
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to use a new imaging drug called 11C-choline that is used with a
PET/CT scan to see prostate cancer when it cannot be seen well on other scans, such as bone
scans, CT or MRI.